CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Tobias Bexte(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Alec Geßner(Goethe University Frankfurt), Vinzenz Särchen(Goethe University Frankfurt), Nawid Albinger(Goethe University Frankfurt), Jan‐Henning Klusmann(Goethe University Frankfurt), Hadeer Mohamed Rasheed(Humboldt-Universität zu Berlin), Michael A. Rieger(Goethe University Frankfurt), Sebastian Wolf(Goethe University Frankfurt), R Bhayadia(Goethe University Frankfurt), Nina Möker(Miltenyi Biotec (Germany)), Jamal Alzubi(University of Freiburg), Olaf Penack(European Society for Blood and Marrow Transplantation), Philipp Wendel(Goethe University Frankfurt), Meike Vogler(Goethe University Frankfurt), Toni Cathomen(University of Freiburg), Katharina Imkeller(Goethe University Frankfurt), Ahmad Al Ajami(Goethe University Frankfurt), Leon Buchinger(Goethe University Frankfurt), Beate Anahita Jung(Humboldt-Universität zu Berlin), Thomas Oellerich(Goethe University Frankfurt)
Cited by 71
Related Papers
Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
|Molecular Cell|2008|709
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
|Genes & Development|2010|218
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
|Blood|2011|189
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185
The non-coding RNA landscape of human hematopoiesis and leukemia
|Nature Communications|2017|164